KT&G to Improve Transparency with Q1 2023 Preliminary Results

Apr.25.2023
KT&G to Improve Transparency with Q1 2023 Preliminary Results
KT&G will announce its Q1 2023 preliminary results on May 11, aiming to increase transparency by disclosing sales and profits by department.

On April 24th, according to a report from Yonhap News Agency, KT&G (Korea Tobacco & Ginseng Corporation) will announce its preliminary performance for the first quarter of 2023 on May 11th.


KT&G has announced its plans to increase transparency to the public. Starting with the release of its latest financial report, KT&G will disclose the sales revenue and operating profit of each of its divisions, which will be categorized into tobacco, dried food, real estate, and other businesses.


In the global tobacco industry, KT&G will further disclose the sales proportion in major overseas regions and provide real-time online streaming for global investors to watch and gain information.


Earlier, KT&G disclosed for the first time the revenue and sales data for its domestic and overseas next-generation tobacco products (NGP) when it reported its Q4 2022 financial performance in February.


According to a report by 2FIRSTS, DS Investment & Securities, a South Korean securities investment company, previously predicted that the NGP business of KT&G and KGC Ginseng Corporation would perform well in the first quarter.


KT&G's comprehensive sales increased by 0.1% year-on-year to 1.4 trillion Korean won in the first quarter, but operating profits fell by 17% to 276.1 billion Korean won, which is expected to fall short of market expectations.


However, the decline in operating profits was offset by strong sales of electronic cigarettes and the new Lil Able model.


According to Zhang Zhihui, a researcher at DS Investment & Securities, the profitability of cigarette sales will continue to weaken in the upcoming quarter due to the rising input costs of tobacco. Additionally, there will be a significant decline in performance due to a drop in sales of the high-profit margin real estate business.


Zhang Zhihui said:


Due to an increase in cigarette production costs and a decline in real estate performance, it is expected that KT&G's annual performance this year will be disappointing.


It has been reported that KT&G has chosen to increase transparency, potentially due to demands from external investors.


Flashlight Capital Partners (FCP) has sent a proposal to KT&G, requesting that they improve transparency regarding investor relations (IR).


In this proposal, FCP requests the proactive notification of an IR schedule and the disclosure of sales performance in both domestic and international regions.


KT&G has stated that it has been actively preparing measures to strengthen its communication with the capital market.


2FIRSTS will continue to monitor the first quarter performance disclosure of KT&G. Stay tuned for updates.


Related Reading:


KT&G, the South Korean tobacco company, has increased its short-term borrowing limit to 800 billion Korean won. It also announced that it will require 39 trillion Korean won for long-term investments.


South Korea may abandon its plan to increase taxes on HNB products, which currently have a tax rate of 90.4% similar to traditional cigarettes.


Fimo International's South Korean subsidiary appoints a new CEO.


KT&G reported a 17% decrease in operating profit in the first quarter, but their new tobacco business showed strong growth.


References:


KT&G will announce its provisional first-quarter results on April 11 and will disclose the operating profits of each division.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

BAT Regional Director Fred Monteiro Supports Spain’s Nicotine Rules but Opposes 0.99mg Nicotine Pouch Limit
BAT Regional Director Fred Monteiro Supports Spain’s Nicotine Rules but Opposes 0.99mg Nicotine Pouch Limit
Spanish newspaper El Confidencial interviewed Fred Monteiro, Regional Director for Americas and Europe at British American Tobacco (BAT). Monteiro said BAT supports setting regulatory limits for nicotine products but opposes Spain’s proposed 0.99mg nicotine-per-pouch limit, arguing that such a restriction could affect adult smokers’ transition to alternatives. He said nicotine regulation should be based on scientific evidence and harm reduction principles. Monteiro also said smoke-free products now account for around 25% of BAT’s Americas and Europe business and nearly 30% of its Europe business
BAT
Jul.30
BAT UK Director Tolga Kilic Says Illicit Nicotine Market Squeezes Legal Retailers Amid Rising Compliance Costs
BAT UK Director Tolga Kilic Says Illicit Nicotine Market Squeezes Legal Retailers Amid Rising Compliance Costs
UK retail publication Grocery Trader has published a viewpoint article from Tolga Kilic, Commercial Director for BAT UK & Ireland, discussing the impact of illicit nicotine products on legitimate retail channels. Kilic said illegal vapes and other illicit nicotine products create competitive pressure for compliant retailers and called for stronger market controls and supply-chain oversight. The comments come as the UK advances policies including the disposable vape ban and Vaping Products Duty, creating a more complex operating environment for legal vape retailers.
Jul.28
French Vape Distributor Kumulus Vape Yields About 3% as Earnings Growth Stalls
French Vape Distributor Kumulus Vape Yields About 3% as Earnings Growth Stalls
Listed French vape distributor Kumulus Vape will trade ex-dividend on June 26, 2026, and pay an annual dividend of €0.10 per share on June 30, with Simply Wall St saying the payout is covered by profit and free cash flow, while weak earnings growth remains a concern.
Industry InsightMarketNews
Jun.24
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
An analysis by We Are Innovation says more than 90% of over 82,000 responses to the European Commission’s public consultation on the Tobacco Products Directive revision raised at least one substantial objection to the proposed regulatory direction.
Jul.13
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04